Microbial factors in chronic intestinal inflammation

Current Opinion in Gastroenterology

Volumn 12, Issue 4, 1996, Pages 327-333

  Sartor, R Balfour ^a   Rath, Heiko C ^a   Sellon, Rance K ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMER;

ANAEROBIC BACTERIUM; BACTERIAL CELL WALL; CHRONIC DISEASE; COLITIS; CROHN DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INTESTINE FLORA; INTESTINE ULCER; LAMINA PROPRIA; REVIEW; ULCERATIVE COLITIS;

EID: 0029832566     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199607000-00003     Document Type: Review

References (47)

1. Sartor RB: Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995, 24:475-508.
2. Sartor RB: Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In Inflammatory Bowel Disease, edn 4. Edited by JB Kirsner, RG Shorter. Baltimore: Williams & Wilkins; 1995:96-124.
3. Elson CO, Sartor RB, Tennyson G, Riddel R: Experimental models of IBD. Gastroenterology 1995, 109:1344-1367. A good overview of several models of IBD that describes the pathology and the key pathogenic features of each.
4. Sartor RB: Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitis. Inflammatory Bowel Dis 1995, 1:64-75.
5. Wakefield AJ, Ekbom A, Dhillon AP, Pittilo RM, Pounder RE: Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995, 108:911-916.
6. Lewin J, Dhillon AP, Sim R, Mazure G, Pounder RE, Wakefield AJ: Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut 1995, 36:564-569.
7. Liu Y, Van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF: Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens In Crohn's disease. Gastroenterology 1995, 108:1396-1404. New evidence that Listeria antigen is found in 75% of Crohn's disease tissue samples, confirmation that normal luminal bacteria secondarily invade ulcers and fistulae. There was no evidence of measles antigens.
8. Iizuka M, Nakagomi O, Chiba M, Ueda S, Masamune O: Absence of measles virus In Crohn's disease. Lancet 1995, 345:660.
9. Thompson NP, Montgomery SM, Pounder RW, Wakefield AJ: Is measles vaccination a risk factor for Inflammatory bowel disease? Lancet 1995, 345:1071-1074.
10. Rowbotham DS, Mapstone NP, Trejdosiewicz LK, Howdle PD, Quirke P: Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. Gut 1995, 37:660-667. IS900 DNA insertion was not detected in gut tissues from 68 patients with Crohn's disease, using a polymerase chain reaction technique with fluorochrome-labeled oligonucleotide primers.
11. Suenaga K, Yokoyama Y, Okazaki K, Yamamoto Y: Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. Am J Gastroenterol 1995, 90:76-80.
12. Kreuzpaintner G, Das PK, Stronkhorst A, Slob AW, Stromeyer G: Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen In Crohn's disease. Gut 1995, 37:361-366. Serum antibodies to the 45- to 48-kD doublet antigen of M. tuberculosis by enzyme-linked immunosorbent assay was specific for Crohn's disease and correlated well with disease activity.
13. Graham DY, Al-Assi MT, Robinson M: Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis infection [abstract]. Gastroenterology 1995, 108:826.
14. Roskell DE, Hyde GM, Campbell AP, Jewell DP, Gray W: HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. Gut 1995, 37:148-150.
15. Iarovici D: Atherosclerosis: not just cholesterol, but chlamydia too? J NIH Res 1995, 8:22-24.
16. Pitcher MCL, Beatty ER, Gibson GR, Cummings JH: Sulfate-reducing bacteria: prevalence in active and inactive ulcerative colitis [abstract]. Gastroenterology 1995, 108:894.
17. Klapproth JM, Donnenberg MS, Abraham JM, Mobley HL, James SP: Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun 1995, 63:2248-2254. A novel observation that bacterial products can inhibit T lymphocytes, demonstrating the extremely complex interplay between enteric bacteria and the mucosal immune system.
18. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK: Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995, 109:516-523.
19. Hilsden RJ, Meddings J, Sutherland LR Intestinal permeability changes in response to acetosalicyclic acid in relatives of patients with Crohn's disease. Gastroenterology 1995, 110:1395-1403.
20. Gardiner KR, Andersone NH, Rowlands BJ, Barbul A: Colitis and colonic mucosal barrier dysfunction. Gut 1995, 37:530-535.
21. Wiedermann U, Hanson LA, Bremell T, Kahu H, Dahlgren UI: Increased translocation of Escherichia coli and development of arthritis in vitamin A deficient rats. Infect Immun 1995, 63:3062-3068.
22. Shroff KE, Meslin K, Cebra JJ: Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut Infect Immun 1995, 63:3904-3913.
23. Kett K, Baklien K, Bakken A, Kral JG, Fausa O, Brandtzaeg P: Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology 1995, 109:819-825.
24. Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME: Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun 1994, 62:5040-5047.
25. Rugtveit J, Haraldsen G, Hogasen AK, Bakka A, Brandtzaeg P, Scott H: Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14(+)L1(+) monocyte derived cells. Gut 1995, 37:367-373. Respiratory burst was significantly reduced after depletion of newly recruited CD14-positive macrophages from the moderately to severely inflamed mucosa from IBD patients.
26. Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, Tytgat GN, van Deventer SJH: Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology 1996, 110:733-739.
27. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ: Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995, 36:897-901. Systemic endotoxemia was found in the vast majority of patients with IBD and correlated positively with different disease activity parameters.
28. Neilly PJD, Gardner KR, Kirk SJ, Jennings G, Anderson NH, Elia M, Rowlands BJ: Endotoxaemia and cytokine production in experimental colitis. Br J Surg 1995, 82:1479-1482.
29. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB: Tissue IL-1 and IL-1 receptor antagonist expression in rat strains variably susceptible to granulomatous enterocolitis. Gastroenterology 1994, 106:960-972.
30. Kuroe K, Haga Y, Funakoshi O, Mizuki I, Kanazawa K, Yoshida Y: Rabbit granulomatous enterocolitis induced by injection of muramyl dipeptide emulsified with Freund's incomplete adjuvant J Gastroenterol 1995, 30:472-477.
31. Jung HC, Eckmann L, Yang S-K, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF: A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995, 95:55-65. This report demonstrates that a columnar epithelial cell line produces a distinctive array of cytokines in response to the presence of pathogenic bacteria at the apical surface.
32. Jobin C, Herfarth HH, Sartor RB: Bacterial products and cytokines upregulate IL-8 gene expression in human colonic epithelial cell lines [abstract]. Gastroenterology 1995, 108:844.
33. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994, 180:2359-2364.
34. Rath HC, Bender DE, Grenther T, Holt LC, Herfarth HH, Mohanty S, Taurog JD, Hammer RE, Sartor RB: Normal bacteria stimulate colonic, gastric, and systemic inflammation in HLA-B27/β2-m transgenic rats [abstract]. Gastroenterology 1995, 108:899.
35. 2u transgenic (TG) rats: a pathogenic role for anaerobic bacteria [abstract]. Clin Immunol Immunopathol 1995, 76(suppl):S45.
36. hi T cells is inhibited by intestinal bacterial decontamination. Clin Immunol Immunopathol 1995, 76:S48-S49.
37. Brandwein SL, McCabe RP, Ridwan BU, Waites KB, Birkenmeier EH, Sundberg JP, Elson CO: Spontaneously colitic C3H/HeJBir mice demonstrate antibody reactivity to isolated colonies of enteric bacteria [abstract]. Gastroenterology 1995, 108:787.
38. Cong Y, Brandwein SL, McCabe RP, Ridwan BU, Birkenmeier EH, Sundberg JP, Elson CO: Th1 response to enteric bacteria in colitis C3H/HeJBir mice [abstract]. Clin Immunol Immunopathol 1995, 76(suppl):S44.
39. Van Kruiningen HJ: On the use of antibiotics in Crohn's disease. J Clin Gastroenterol 1995, 20:310-316.
40. Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninck F, Aerts R, Kerremans R: Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995, 108:1617-1621. Metronidazole had a beneficial effect on severe recurrence of Crohn's disease after ileal resection and on the recurrence rate after 1 year.
41. Greenbloom SL, Steinhart AH, Greenberg GR: Ciprofloxacin and metronidazole: combination antibiotic therapy for ileocolonic Crohn's disease [abstract]. Gastroenterology 1995, 108:826.
42. Demling J: Crohn's disease caused by antibiotics? Hepatogastroenterology 1994, 41:549-551.
43. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Rossi SS, Hofmann AF, Gores GJ, Phillips SF: Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995, 40:1474-1483.
44. Lichtman SN, Wang J, Sartor RB, Zhang C, Bender D, Dalldorf FG, Schwab JH: Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines. bacteria and bacterial polymers. Infect Immun 1995, 63:2295-2301. Normal enteric bacteria, in particular anaerobes, and PG-PS polymers are able to cause a relapse of arthritis in the animal previously primed with an intra-articular injection of PG-PS polymers.
45. Sun X-M, MacKendrick W, Tien J, Huang W, Caplan MS, Hsueh W: Endogenous bacterial toxins are required for the injurious action of platelet activating factor in rats. Gastroenterology 1995, 109:83-88.
46. Lichtman SN, Sartor RB: Extraintestinal manifestations of IBD. In Inflammatory Bowel Disease: From Bench to Bedside. Edited by Targan S, Shanahan F. Baltimore: Williams & Wilkins; 1993:317-335.
47. Sartor RB: Role of intestinal flora in initiation and perpetuation of IBD. Can J Gastroenterol 1990, 4:271-277.